AVEO: Michael Bailey, president and chief executive officer, will be presenting at the following investor conferences:
The 19th Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 12, 2017
The Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017
Technical indicators showing continued upward momentum with RSI and MACD in bullish territory. Float of 117.5M with 7.8% short. Volume on Thursday was almost 3 x the EMA(20) VOLUME. Initial PT of $4.30.
NKTR: Presented clinical data on September 6th from the SUMMIT-07 Phase 3 study of NKTR-181, a first-in-class opioid analgesic to treat chronic pain, at the 2017 PAINWeek® Conference in Las Vegas taking place September 5-9. In addition, President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 2017 Morgan Stanley Global Healthcare Conference in New York City on Tuesday, September 12, 2017.
Technical indicators continue to show strength. There are 2 resistance lines coming into play soon. First at 23.60, then 24.25. Looking for an initial PT of 23.50.
NVAX: The Company participated in Citi’s 12th Annual Biotech Conference on Thursday. Novavax is presently attempting to development an F-protein nanoparticle RSV vaccine that can be administered in conjunction with seasonal flu shots in elderly patients, as well as a vaccine for pregnant mothers that can confer immunity to newborns during the first few months of their lives.
Technically, its following a nice channel and appears to be heading towards 1.35 - 1.40.
OSUR: A leader in point of care diagnostic tests and specimen collection devices announced that Douglas A. Michels, President and CEO, will speak to the investment community at CL King’s 15th Annual Best Ideas Conference on September 14th. This Zacks Rank #2 stock promises long-term expected earnings growth of 16%. Notably, OraSure has a Growth Style Score of B.
A beautiful chart showing a price increase of over 50% since May. Looking for more appreciation in the price upto 24.00 in the near term.
ARDX: It has a small float of only 47M. Up almost 25% since reporting a Earnings loss on August 9th. Looks like it wants to fill the gap and get back to 8.00 in the short term.